Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control: Editorial to: “Secondary Prevention of Coronary Disease with ACE Inhibition—Does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?” by Remme et al.

By Verma Anil   Ventura Hector  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite

The Effects of Blood Pressure and Lipid Control on Kidney Allograft Outcome

By El-Amm Jose-Marie   Haririan Abdolreza   Crook Errol D.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 1, 2006-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

ACE Inhibition with Moexipril: A Review of Potential Effects Beyond Blood Pressure Control

By Pines A.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 351-360

Adis International

Access to resources Recommend Favorite

Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Perindopril for Control of Blood Pressure in Patients with Hypertension and Other Cardiovascular Risk Factors: An Open-Label, Observational, Multicentre, General Practice-Based Study

By Richard Ian Ogilvie  

Clinical Drug Investigation, Vol. 28, Iss. 11, 2008-01 ,pp. : 673-686

Adis International

Access to resources Recommend Favorite